An intelligent search tool for clinical trials

Sign In
Back|NCT05663203Recruiting
Official Title

A Web-Based Dyadic Intervention to Manage Psychoneurological Symptoms for Patients With Colorectal Cancer and Their Caregivers

Sponsor
Emory University
Enrollment
56
Timeline
May 2023 → Oct 2027
About This Study

This clinical trial studies how well a web-based dyadic intervention works to manage psychoneurological symptoms for patients with colorectal cancer and their caregivers. Patients with colorectal cancer receiving chemotherapy experience severe and distressing psychoneurological symptoms that include fatigue, depression, sleep disturbance, pain, and cognitive dysfunction. When these co-occurring symptoms are undertreated, they negatively affect functional status, survival rates, and quality of life of patients as well as decrease health outcomes of their family caregiver. A critical need exists to develop an effective and novel intervention that focuses on patients with colorectal cancer receiving chemotherapy and their caregivers. A web-based dyadic intervention holds great promise to reduce psychoneurological symptoms burden and improve quality of life for patients with colorectal cancer receiving chemotherapy and advance intervention development and implementation in cancer supportive care and health equity.

Eligibility Criteria

Inclusion Criteria

  • 1Patients:
  • 2Age \>= 18 years
  • 3Diagnosed with colorectal cancer
  • 4Life expectancy \> 12 months
  • 5Receiving active chemotherapy
  • 6Self-reported at least two psychoneurological symptoms (based on the symptom measures' cutoff scores)
  • 7Identified primary caregiver (i.e., family members or significant others identified by the patients as their primary source of emotional and physical support)
  • 8Access to the Internet
  • 9Fluent in English
  • 10Caregivers:
  • 11Age \>= 18 years
  • 12Primary caregiver
  • 13Access to the Internet
  • 14Fluent in English

Exclusion Criteria

  • 1Patients:
  • 2Karnofsky Performance Scale \< 50
  • 3Caregivers:
  • 4Have severe diseases (e.g., cancer, heart disease)

Locations

1 site participating in this study

Emory University/Winship Cancer Institute

Atlanta, Georgia 30322

Recruiting
Data sourced from ClinicalTrials.govView on ClinicalTrials.gov →